Nonmechanical Small Bowel Obstruction in a Patient on Zepbound Without a Surgical History: A Case Report.

Publication/Presentation Date

8-1-2025

Abstract

We present the case of a 52-year-old woman who developed a functional small bowel obstruction despite having no history of abdominal surgery, prior bowel obstruction, or GI interventions. The only notable recent change in her medical history was a dose escalation of Zepbound (tirzepatide), a glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide agonist prescribed for weight loss. This case raises concern about potential severe GI motility complications associated with Zepbound, particularly in the absence of conventional SBO risk factors.

Volume

17

Issue

8

First Page

90657

Last Page

90657

ISSN

2168-8184

PubMedID

40978855

Department(s)

Medical Education

Document Type

Article

Share

COinS